Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis

• Główni autorzy: Xiangge Ren (Autor), Miaomiao Zhang (Autor), Xiaohan Zhang (Autor), Peidong Zhao (Autor), Wensheng Zhai (Autor)
• Format: Książka
• Wydane: BMC, 2024-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). Higher doses of IVIg are associated with a more insupportable financial burden to pediatric patients' families and may produce more adverse reactions. Whether lo...